These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17155854)

  • 21. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
    Jayakar SS; Dikshit M
    Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Parkinson's disease : what's on the horizon?
    Wu SS; Frucht SJ
    CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationally designed multi-targeted agents against neurodegenerative diseases.
    Geldenhuys WJ; Van der Schyf CJ
    Curr Med Chem; 2013; 20(13):1662-72. PubMed ID: 23410161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W; Schulz JB
    J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Map kinase signaling as therapeutic target for neurodegeneration.
    Ahmed T; Zulfiqar A; Arguelles S; Rasekhian M; Nabavi SF; Silva AS; Nabavi SM
    Pharmacol Res; 2020 Oct; 160():105090. PubMed ID: 32707231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis in neurodegenerative disorders.
    Mattson MP
    Nat Rev Mol Cell Biol; 2000 Nov; 1(2):120-9. PubMed ID: 11253364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.
    Fan D; Liu L; Wu Z; Cao M
    Curr Neuropharmacol; 2019; 17(6):563-579. PubMed ID: 29676231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium ions in neuronal degeneration.
    Wojda U; Salinska E; Kuznicki J
    IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROCK inhibition in models of neurodegeneration and its potential for clinical translation.
    Koch JC; Tatenhorst L; Roser AE; Saal KA; Tönges L; Lingor P
    Pharmacol Ther; 2018 Sep; 189():1-21. PubMed ID: 29621594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review.
    Rekatsina M; Paladini A; Piroli A; Zis P; Pergolizzi JV; Varrassi G
    Adv Ther; 2020 Jan; 37(1):113-139. PubMed ID: 31782132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
    Waldmeier PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches.
    Bolognin S; Cozzi B; Zambenedetti P; Zatta P
    J Alzheimers Dis; 2014; 41(1):29-42. PubMed ID: 24577478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Natural Compounds in Neurodegenerative Disorders.
    Srivastava P; Yadav RS
    Adv Neurobiol; 2016; 12():107-23. PubMed ID: 27651251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
    Pisani L; Catto M; Leonetti F; Nicolotti O; Stefanachi A; Campagna F; Carotti A
    Curr Med Chem; 2011; 18(30):4568-87. PubMed ID: 21864289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Perspectives of Taxifolin in Neurodegenerative Diseases.
    Yang R; Yang X; Zhang F
    Curr Neuropharmacol; 2023; 21(10):2097-2109. PubMed ID: 36740800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders.
    Volcho KP; Laev SS; Ashraf GM; Aliev G; Salakhutdinov NF
    Curr Med Chem; 2018; 25(39):5327-5346. PubMed ID: 28079000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.